An AI tool that produces impressive answers is not necessarily an AI tool you should trust. The real test is whether you can demonstrate its accuracy, security, fairness, and reliability.

Did you know?

Your organization has just invested in a new AI platform. The demonstration was impressive. It summarized documents in seconds, generated reports, answered complex questions, and automated tasks that previously required hours of manual effort.

The leadership team is excited. The project team is ready to deploy. The business case promises productivity, efficiency, and cost savings.

But there is one question that deserves more attention:

How do we prove that this AI tool is actually right, safe, and suitable for the work we intend to give it?

An AI system can produce convincing answers that are inaccurate. It can process information efficiently while exposing confidential data. It can perform well during a demonstration but fail when users, data, or business conditions change.

The distinction is critical:

• A successful demonstration proves that a tool can perform a task under selected conditions.
• A successful evaluation provides evidence of how well it performs across defined scenarios.
• A responsible deployment demonstrates that its risks are understood, its controls are working, and its performance is monitored.

For AI leadership teams, this is no longer just a technology question. It is a matter of business assurance, risk management, customer trust, and organizational accountability.

The objective is not to prove that AI is perfect. It is to establish credible evidence that an AI tool is fit for its intended purpose, that its limitations are understood, and that the organization can manage what happens when it gets something wrong.

1. What does it mean to prove an AI tool is right and safe?

Before adopting an AI solution, organizations should evaluate two connected dimensions: whether the tool is fit for purpose and whether it can be operated responsibly.

Is it right? — Fitness and performance

• Does it produce accurate and relevant results?
• Does it use reliable and appropriate data?
• Can its outputs be verified?
• Does it perform consistently across realistic scenarios?
• Does it communicate uncertainty and recognize its limitations?

Is it safe? — Trustworthiness and risk

• Does it protect confidential and personal information?
• Does it resist malicious inputs and unauthorized access?
• Does it produce unfair or discriminatory outcomes?
• Can users understand when and how AI is being used?
• Is there meaningful human oversight?
• Can the organization trace, correct, or stop harmful behavior?

These questions apply whether the organization is purchasing a commercial AI product, developing an internal model, deploying a generative AI assistant, or introducing autonomous agents.

A tool should never be approved simply because its vendor says it is enterprise-ready or because it performs well in a sales demonstration.

2. Why should the C-suite care?

AI adoption is accelerating, but the consequences of a poor deployment can extend far beyond the technology department.

Imagine an AI recruitment tool that consistently ranks candidates. If its recommendations disadvantage qualified applicants, the organization may face discrimination concerns, legal exposure, and reputational damage.

Imagine a financial AI assistant that generates a convincing but incorrect compliance interpretation. If employees rely on it without verification, the organization may make decisions based on false information.

Imagine an autonomous agent with access to enterprise applications. If its permissions are excessive, an incorrect instruction or malicious input could lead to unauthorized actions or data exposure.

For executives, the business case must therefore include more than productivity and return on investment.

 

Leadership takeaway: AI assurance is not an obstacle to innovation. It is the evidence that makes sustainable innovation possible.

3. Real-world lessons: When convincing AI outputs are not enough

The need to validate AI is not theoretical. Real-world incidents and security assessments demonstrate why organizations must test systems under realistic conditions.

Case study 1: Air Canada — A confident answer can still be wrong

In Moffatt v. Air Canada (2024 BCCRT 149), a customer relied on Air Canada's chatbot for information about bereavement fares. The chatbot provided incorrect information about applying for a reduced fare retroactively.

The British Columbia Civil Resolution Tribunal found Air Canada liable for negligent misrepresentation and ordered compensation. The decision demonstrated that an organization cannot simply distance itself from inaccurate information because it was generated by a chatbot. Case decision and analysis.

What can organizations learn?

A customer-facing AI assistant must be tested against current, authoritative business policies—not just generic questions.

Practical controls include:

• Validate answers against approved knowledge sources.
• Test high-impact customer questions and edge cases.
• Provide clear escalation to a human representative.
• Monitor incorrect answers and customer complaints.
• Assign a business owner accountable for the information presented.

Project manager's lesson: Accuracy testing must include real business scenarios and customer journeys, not just sample prompts selected for a product demonstration.

Case study 2: Google Cloud Mandiant — An AI tool can become a security weakness

Google Cloud's Mandiant team documented security weaknesses identified during assessments of AI applications and agentic systems.

In one assessment, testers identified a vulnerability in an agentic tool used by a generative AI chatbot. Exploiting the vulnerability allowed recovery of a cloud SaaS integration API key, which the agent used to query sensitive service-ticket information.

Mandiant also documented examples of excessive agency, where agents could access information or perform actions beyond their intended permissions. Google Cloud — AI Risk and Resilience.

What can organizations learn?

A tool can be accurate and still be unsafe.

AI security assessments should examine:

• Access permissions and identity controls.
• API security and credential management.
• Prompt injection and malicious inputs.
• Data leakage and unauthorized access.
• Agent actions and tool-call restrictions.
• Logging, monitoring, and incident response.

Project manager's lesson: Security testing must cover the entire AI solution—including connected applications, APIs, data sources, and third-party integrations.

Case study 3: AI-enabled medical devices — Safety requires lifecycle evidence

The U.S. Food and Drug Administration (FDA) regulates medical devices, including qualifying AI-enabled medical device software, using a risk-based approach. Its work emphasizes safety and effectiveness across the product lifecycle.

The FDA's published guidance and resources address design, development, validation, transparency, performance monitoring, and changes to AI-enabled device software. It also highlights the importance of understanding model limitations, data characteristics, and performance changes after deployment. FDA — Artificial Intelligence-Enabled Medical Devices.

What can organizations learn?

Testing before release is essential, but it is not the end of assurance. Performance can change when the system encounters different users, environments, or data.

Project manager's lesson: Build post-deployment monitoring, change management, and revalidation into the project plan from the beginning.

Together, these examples reveal three important truths:

1. A plausible answer is not necessarily a correct answer.
2. A useful AI capability is not necessarily a secure capability.
3. A successful launch does not guarantee continued safety and effectiveness.

4. The AI Assurance Framework: Seven steps to prove fitness and safety

How can leadership teams translate these lessons into an actionable process?

Consider the following seven-step framework.

Step 1: Define the intended purpose

Start by identifying exactly what the AI tool is expected to do.

Document:

• Business problem and intended users.
• Approved use cases and prohibited uses.
• Decisions the AI may support or make.
• Types of data it will process.
• Potential impact on customers, employees, and other stakeholders.
• Consequences of incorrect outputs.

For example, an AI assistant may be approved to summarize financial reports but not to independently approve financial transactions.

The intended purpose determines what must be tested and what level of assurance is appropriate.

Step 2: Validate the data

AI quality depends heavily on the data used to train, configure, retrieve information for, or evaluate the system.

Ask:

• Is the data accurate, relevant, and current?
• Is its source documented?
• Is it representative of the intended users and operating environment?
• Does it contain sensitive or personal information?
• Are permissions and usage rights appropriate?
• Are there missing values, duplicates, or inconsistencies?

For retrieval-augmented generation (RAG) systems, also validate the documents in the knowledge base, retrieval quality, source references, and how the system handles missing or conflicting information.

Practical example: An HR assistant trained or configured using outdated employee policies may confidently provide incorrect leave or benefits information. Updating the knowledge base and testing responses against approved policy documents should be part of release readiness.

Step 3: Test accuracy and reliability

Do not rely on a handful of successful prompts.

Build a representative evaluation dataset containing:

• Common business scenarios.
• Complex and ambiguous requests.
• Edge cases and unusual inputs.
• Incorrect or incomplete information.
• Conflicting data sources.
• Questions the system should refuse or escalate.

Define measurable acceptance criteria before testing.

Possible measures include:

Metrics must be selected according to the application. A classification model, a RAG assistant, and an autonomous agent require different evaluation methods.

For generative AI, include human evaluation of factual accuracy, unsupported claims, completeness, and usefulness. Automated scores alone may not capture business impact.

Step 4: Conduct safety, security, and fairness testing

An AI tool should be challenged before it is trusted.

Test for:

• Bias and discriminatory outcomes.
• Privacy violations and sensitive-data exposure.
• Prompt injection and adversarial manipulation.
• Unauthorized access and excessive permissions.
• Inappropriate or harmful outputs.
• Misuse of connected tools and APIs.
• Failure to recognize uncertainty.
• Unsafe autonomous actions.

For example, a recruitment assistant should be tested across relevant applicant groups and evaluated for potentially discriminatory patterns. A finance agent should be tested against duplicate invoices, manipulated instructions, and unauthorized payment requests.

Document identified risks, severity, mitigation, and residual risk.

Step 5: Validate human oversight and accountability

AI should not become an accountability escape route.

Define:

• Who owns the AI use case?
• Who approves its deployment?
• Which decisions require human review?
• Who can override or suspend the system?
• How are errors and complaints escalated?
• Who is responsible for remediation?

For high-impact decisions, human oversight should be meaningful. Reviewers need sufficient information, competence, authority, and time to challenge AI recommendations.

A human approval button is not meaningful oversight if the reviewer cannot understand the decision or realistically question it.

Step 6: Monitor performance after deployment

AI assurance must continue after launch.

Monitor:

• Accuracy and reliability.
• Data and model drift.
• User feedback and complaints.
• Security events and unauthorized access.
• Bias and fairness indicators.
• Changes in connected systems and data sources.
• Cost, latency, and operational availability.
• Human overrides and escalations.

Define thresholds that trigger investigation, additional testing, rollback, restricted use, or suspension.

The FDA's work on AI-enabled medical devices illustrates why lifecycle monitoring matters: performance changes in real-world environments can introduce risks that pre-deployment testing alone may not fully address.

Step 7: Maintain evidence and independent review

If an organization claims that its AI tool is safe, it should be able to demonstrate why.

Maintain an AI assurance evidence pack containing:

• Intended-use statement.
• AI system and vendor documentation.
• Data provenance and quality assessment.
• Risk assessment and mitigation plan.
• Evaluation datasets and test results.
• Security and privacy assessment.
• Fairness and human-oversight assessment.
• Approval records and known limitations.
• Monitoring plan and incident procedures.
• Change history and reassessment records.

For higher-risk applications, consider independent technical, security, legal, or domain-expert review.

The objective is not paperwork. It is traceable evidence that the organization has assessed the system, understood its limitations, and implemented controls appropriate to its use.

5. A practical example: Proving an AI project-management assistant is fit for use

Imagine a company introducing an AI assistant to help project managers generate status reports, identify risks, summarize meeting minutes, and recommend corrective actions.

The tool promises to save time and improve project visibility.

How should the organization validate it?

A responsible deployment could begin with a pilot involving a limited number of project teams.

During the pilot:

1. Compare AI-generated reports with project-manager-approved reports.
2. Track factual errors and unsupported recommendations.
3. Test access restrictions using different user roles.
4. Collect feedback from project managers.
5. Define acceptable performance thresholds.
6. Obtain business and governance approval before scaling.

The tool should not independently change baselines, approve budget increases, or reassign resources unless those actions are explicitly authorized and appropriately controlled.

This approach allows the organization to capture productivity benefits while retaining professional judgment and accountability.

6. The project manager's role: Make AI assurance part of delivery

Project managers can turn AI assurance from an abstract governance requirement into practical delivery activities.

A useful practice is to create an AI Assurance Gate before production release.

The gate should confirm that:

• Intended use is documented.
• Evaluation criteria have been met.
• Significant risks have been addressed or formally accepted by authorized owners.
• Human oversight is operational.
• Security and privacy controls have been reviewed.
• Monitoring and incident-response procedures are ready.
• Required evidence is retained.

This makes AI quality and safety visible within the project's normal governance and stage-gate processes.

7. Frameworks that help establish confidence

Organizations do not need to create every assurance process from scratch. Established frameworks and guidance provide useful foundations.

NIST AI Risk Management Framework (AI RMF)

NIST's voluntary AI RMF helps organizations incorporate trustworthiness considerations into the design, development, use, and evaluation of AI systems. Its four functions—Govern, Map, Measure, and Manage—provide a practical structure for identifying context, evaluating performance, and managing risk.

The NIST Generative AI Profile adds guidance on risks associated with generative AI. NIST AI RMF.

ISO/IEC 42001 — AI Management Systems

ISO/IEC 42001 provides requirements and guidance for establishing, implementing, maintaining, and continually improving an AI management system. It can help organizations establish governance responsibilities and systematic management processes.

OWASP Top 10 for LLM Applications and Agentic Applications

OWASP resources help security teams identify vulnerabilities such as prompt injection, sensitive information disclosure, insecure integrations, and excessive agency. They can support threat modeling and technical testing. OWASP GenAI Security Project.

FDA guidance for AI-enabled medical devices

For applicable medical-device use cases, FDA resources provide specific expectations and recommendations concerning safety, effectiveness, transparency, and lifecycle management. These are sector-specific resources, not general approval requirements for every AI tool. FDA AI-enabled medical devices.

No single framework guarantees that an AI tool is safe. Organizations should select and combine relevant practices according to the intended use, impact, industry, and applicable legal requirements.

8. The C-suite dashboard: What should leadership measure?

Executives need a concise view of whether AI systems are delivering value while remaining within acceptable risk boundaries.

Consider the following indicators:

Metrics should be risk-based and interpreted in context. For example, a higher number of reported issues may indicate stronger monitoring and reporting rather than declining system quality.

The executive review should move beyond asking, “How many AI tools have we deployed?”

It should ask:

• Which tools have been evaluated?
• What evidence supports their approval?
• What limitations are known?
• What risks remain?
• Who owns those risks?
• How do we know the controls are still working?

9. A 30-day AI assurance challenge

Leadership teams can begin with a focused 30-day initiative.

Week 1 — Identify and define

Inventory AI tools and use cases. Document intended purpose, business owners, users, data sources, and potential impact.

Week 2 — Evaluate and challenge

Create representative test scenarios. Assess accuracy, security, privacy, fairness, reliability, and failure behavior.

Week 3 — Control and approve

Define acceptance criteria, remediation actions, human oversight, access restrictions, and release approval responsibilities.

Week 4 — Monitor and demonstrate

Establish performance dashboards, incident procedures, reassessment triggers, and an evidence pack. Pilot the assurance process on one priority AI use case.

At the end of 30 days, the organization may not have proved every AI system safe for every possible scenario. It should, however, have a repeatable method for determining which tools are fit for which purposes—and what evidence is still missing.

Final thoughts: Trust must be demonstrated, not assumed

AI can produce remarkable results. It can accelerate analysis, improve productivity, support decisions, and help organizations solve complex problems.

But a confident answer is not proof of correctness. A successful demonstration is not proof of safety. And a vendor's assurance is not a substitute for an organization's own due diligence.

For executives, the responsibility is to demand evidence before approving AI adoption and to ensure that accountability remains clear.

For project managers, the opportunity is to integrate validation, risk assessment, testing, and monitoring into every stage of AI delivery.

For technology and governance teams, the challenge is to make assurance measurable, repeatable, and continuous.

The most trusted AI organizations will not be those that claim their tools never fail. They will be those that understand where their tools can fail, test those boundaries, respond when problems occur, and continuously improve.

“Do not ask only what your AI tool can do. Ask what evidence proves it does the right thing, protects what matters, and remains safe when conditions change. Trust in AI is not a feature to purchase—it is a standard to demonstrate.”